Request Demo
Last update 01 Nov 2025
HR-011408
Last update 01 Nov 2025
Overview
Basic Info
Drug Type Hormone |
Synonyms HR 011408, HR-011408, HR011408 |
Target |
Action agonists |
Mechanism INSR agonists(Insulin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with HR-011408CTR20241366
比较HR011408与诺和锐®在糖尿病患者中的药代动力学（PK）和药效动力学（PD）研究——随机、双盲、三周期交叉设计I期临床试验
[Translation] Comparison of the pharmacokinetics (PK) and pharmacodynamics (PD) of HR011408 and NovoRapid® in patients with diabetes - a randomized, double-blind, three-period crossover design Phase I clinical trial
NCT06375031
Comparing Pharmacokinetics and Pharmacodynamics Between HR011408 and NovoRapid® in Subjects With Diabetics- A Randomized, Double-Blind, Three-cycle Crossover Phase I Clinical Trial
CTR20230415
比较HR011408与诺和锐®在健康受试者中的药代动力学（PK）和药效动力学（PD）研究——单中心、随机、双盲、双周期、双序列交叉设计I期临床试验
[Translation] Comparative study of the pharmacokinetics (PK) and pharmacodynamics (PD) of HR011408 and NovoRapid® in healthy subjects - a single-center, randomized, double-blind, two-period, double-sequence crossover design Phase I clinical trial
100 Clinical Results associated with HR-011408
Login to view more data
100 Translational Medicine associated with HR-011408
Login to view more data
100 Patents (Medical) associated with HR-011408
Login to view more data
100 Deals associated with HR-011408
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 1 | Phase 1 | China | 01 May 2024 | |
| Diabetes Mellitus, Type 2 | Phase 1 | China | 01 May 2024 | |
| Diabetes Mellitus | Phase 1 | - | 29 Nov 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free